5/17/2022 6:17:25 AM
MannKind Enters Deal To Acquire V-Go Insulin Delivery Device From Zealand Pharma
10/4/2021 7:06:44 AM
MannKind Enrolls First Patient Enrolled In Inhale-1 Study Of Afrezza® In Pediatric Population
9/7/2021 6:02:47 AM
United Therapeutics Presents Tyvaso DPI BREEZE Clinical Data At European Respiratory Society International Congress 2021
8/4/2021 6:54:10 AM
MannKind Partners With NRx Pharm To Explore Dry Powder Formulation Of ZYESAMI Based On Technosphere Platform
6/16/2021 11:02:35 AM
MannKind : FDA Accepts For Priority Review Of NDA For Tyvaso DPI For Treatment Of PAH And PH-ILD
6/3/2021 6:03:41 AM
MannKind Presents A Post Hoc Analysis From STAT Study
4/19/2021 6:08:32 AM
MannKind, United Therapeutics Reach Milestone In Development Of Tyvaso DPI
3/2/2021 6:36:16 AM
MannKind Prices Upsized $200.0 Mln Convertible Senior Notes Offering